Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030
- PMID: 38530431
- DOI: 10.1007/s00403-024-02846-z
Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030
Abstract
Background: Millions of people worldwide are affected by psoriasis, one of the most prevalent skin conditions. Currently, there is a lack of high-quality epidemiological reports on psoriasis.
Objective: This study aimed to reveal trends in psoriasis epidemiology in 1990-2019.
Methods: Using data from the GBD study 2019, we examined psoriasis epidemiology globally and across regions defined by the social-demographic index (SDI). Trends in incidence, prevalence, and disability-adjusted life year (DALY) rates were assessed using estimated annual percentage changes (EAPC)s. Age-period-cohort analysis examined risk variations, and decomposition analysis identified factors impacting the psoriasis burden. A Bayesian Age-Period-Cohort model predicted future incidence. Frontier analysis associated psoriasis outcomes with socio-demographic development.
Results: In 2019, the global psoriasis burden included 4,622,594 incidence, 40,805,386 prevalence, and 3,505,736 DALY cases. Despite variations in SDI regions, the overall trend showed a decline in psoriasis rates from 1990 to 2019 (EAPC = - 0.76). The age-specific analysis indicated that the highest incidence of psoriasis was observed among individuals aged 40-64 years (global, 1,606,429). Epidemiological shifts contributed negatively to global incidence and DALYs by - 80.52% and - 103.06%, respectively. Countries like San Marino and Spain displayed the highest effective differences in the decomposition analysis. By 2030, while incidence cases per 10,000 might rise (487.36, 423.62 to 551.10), age-standardized incidence rates per 100,000 were predicted to decline (53.67, 0.00 to 259.99).
Conclusion: This research revealed a global decline in psoriasis incidence rate from 1990 to 2019, with predictions suggesting this trend continues through 2030. Geographic disparities underscore the importance of tailored healthcare policies.
Keywords: Bayesian age-period-cohort (BAPC) model; Frontier analysis; Global burden of disease; Incidence; Psoriasis.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Boehncke W-H, Schön MP (2015) Psoriasis. Lancet 386(9997):983–994. https://doi.org/10.1016/S0140-6736(14)61909-7 - DOI - PubMed
-
- Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN (2021) Psoriasis. Lancet 397(10281):1301–1315. https://doi.org/10.1016/S0140-6736(20)32549-6 - DOI - PubMed
-
- World Health Organization (2016) Global report on psoriasis. World Health Organization, Geneva
-
- Michalek IM, Loring B, John SM (2017) A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 31(2):205–212. https://doi.org/10.1111/jdv.13854 - DOI - PubMed
-
- Prignano F, Rogai V, Cavallucci E, Bitossi A, Hammen V, Cantini F (2018) Epidemiology of psoriasis and psoriatic arthritis in Italy-a systematic review. Curr Rheumatol Rep 20(7):43. https://doi.org/10.1007/s11926-018-0753-1 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical